Literature DB >> 8304310

Impairment of salivary epidermal growth factor secretory response to esophageal mechanical and chemical stimulation in patients with reflux esophagitis.

R M Rourk1, Z Namiot, J Sarosiek, Z Yu, R W McCallum.   

Abstract

OBJECTIVES: It has been demonstrated recently that salivary epidermal growth factor (sEGF) output in healthy individuals is strongly and significantly influenced by esophageal intraluminal mechanical and chemical stimuli. Therefore, we have studied the impact of intraesophageal mechanical and chemical stressors on the rate of secretion of sEGF in 14 patients with reflux esophagitis (RE), and compared these results with corresponding parameters measured in 14 sex- and age-matched controls.
METHODS: EGF was assessed in saliva collected during basal conditions, chewing of parafilm, placement of esophageal tubing, inflation of intraesophageal balloons, and perfusion with NaCl, HCl, and HCl/pepsin solutions. The concentration of sEGF was measured with an RIA kit from Amersham (Arlington Heights, IL).
RESULTS: The concentrations of sEGF were (mean +/- SEM) 2.50 +/- 0.32 ng/ml and 2.00 +/- 0.37 ng/ml in basal saliva and during stimulation by chewing the parafilm, respectively. Basal sEGF value appeared to be significantly higher than in controls (2.50 +/- 0.32 vs. 1.90 +/- 0.22 ng/ml, p < 0.05, in one-tailed t test). Placement of intraesophageal tubing resulted in a significant decline of sEGF concentration, compared with parafilm-stimulated conditions (1.25 +/- 0.12 vs. 2.00 +/- 0.37 ng/ml, p < 0.0001) and corresponding tubing-stimulated sEGF value in controls (1.25 +/- 0.12 vs. 1.52 +/- 0.16 ng/ml, p < 0.05). sEGF concentrations after inflation of intraesophageal balloons and subsequent perfusion with initial saline, HCl, HCl/pepsin, and ending saline were also highly significantly lower (1.05 +/- 0.18 ng/ml, p < 0.001; 1.10 +/- 0.20 ng/ml, p < 0.001; 1.10 +/- 0.18 ng/ml, p < 0.001; 1.10 +/- 0.19 ng/ml, p < 0.001; and 1.05 +/- 0.18 ng/ml, p < 0.001, respectively) than sEGF concentration recorded during stimulation with parafilm. Concentrations of sEGF during esophageal perfusion with HCl, HCl/pepsin, and ending saline were also significantly lower than corresponding values in controls (1.10 +/- 0.18 vs. 1.49 +/- 0.11 ng/ml, p < 0.05; 1.10 +/- 0.19 vs. 1.59 +/- 0.11 ng/ml, p < 0.05; and 1.05 +/- 0.18 vs. 1.65 +/- 0.13 ng/ml, p < 0.01, respectively). The rate of sEGF output, which was 1.30 +/- 0.24 ng/min during basal conditions, increased significantly during stimulation with parafilm (2.30 +/- 0.38 ng/min, p < 0.05). Both basal and parafilm-stimulated sEGF outputs were somewhat higher, although nonsignificantly, than corresponding values recorded in healthy individuals. Mechanical and chemical stimulation (initial NaCl, HCl, and ending NaCl) failed to evoke a significant increase in sEGF output over the value observed during parafilm stimulation in patients with RE, although such a significant increase was clearly demonstrated in healthy individuals. Therefore, sEGF output in patients with RE remained significantly lower than corresponding values recorded in controls during an entire mechanical stimulation (2.65 +/- 0.35 vs. 4.60 +/- 0.85 ng/min, p < 0.001, after placement of intraesophageal tubing and 2.80 +/- 0.54 vs. 5.15 +/- 0.70 ng/min, p < 0.001, after inflation of balloons). sEGF output in patients with RE remained also significantly lower than adequate control values during chemical stimulation (3.65 +/- 0.64 vs. 5.20 +/- 0.60 ng/min, p < 0.05, during perfusion with initial saline; 3.70 +/- 0.70 vs. 5.20 +/- 0.60 ng/min, p < 0.05, during perfusion with HCl; 3.70 +/- 0.52 vs. 5.55 +/- 0.72 ng/min, p < 0.01, during perfusion with HCl/pepsin, and 3.30 +/- 0.56 vs. 5.80 +/- 0.86 ng/min, p < 0.001, during ending saline).
CONCLUSION: Impairment in sEGF secretion during mechanical and chemical intraesophageal stimulation, mimicking the natural scenario occurring during gastroesophageal reflux, may facilitate the development of esophageal mucosal pathology and delay the healing of already developed mucosal injury.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8304310

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  9 in total

1.  Sympathetic Nerve Entrapment Point Injection as an Antireflux Procedure for Refractory Laryngopharyngeal Reflux: A First Case Report of Innovative Autonomic Regulation.

Authors:  Sangsoo Lee; Chang Jin Oh; Jeong Won Seong
Journal:  Innov Clin Neurosci       Date:  2016-12-01

2.  Salivary bicarbonate as a major factor in the prevention of upper esophageal mucosal injury in gastroesophageal reflux disease.

Authors:  Tomasz Skoczylas; Harathi Yandrapu; Cezary Poplawski; Mazen Asadi; Grzegorz Wallner; Jerzy Sarosiek
Journal:  Dig Dis Sci       Date:  2014-03-09       Impact factor: 3.199

3.  Salivary growth factors and cytokines are not deficient in patients with gastroesophageal reflux disease or Barrett's esophagus.

Authors:  K Kongara; G Varilek; E E Soffer
Journal:  Dig Dis Sci       Date:  2001-03       Impact factor: 3.199

Review 4.  Metabolic syndrome and gastrointestinal diseases.

Authors:  Sumio Watanabe; Mariko Hojo; Akihito Nagahara
Journal:  J Gastroenterol       Date:  2007-04-26       Impact factor: 7.527

Review 5.  Molecular pathways and genetic factors in the pathogenesis of laryngopharyngeal reflux.

Authors:  Alexios S Vardouniotis; Alexander D Karatzanis; Eleni Tzortzaki; Elias Athanasakis; Katerina D Samara; Georgios Chalkiadakis; Nikolaos Siafakas; George A Velegrakis
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-04-02       Impact factor: 2.503

6.  Gastric juice prostaglandins and peptide growth factors as potential markers of chronic atrophic gastritis, intestinal metaplasia and gastric cancer: their potential clinical implications based on this pilot study.

Authors:  Ajoy Dias; Cesar Garcia; Marek Majewski; Grzegorz Wallner; Richard W McCallum; Cezary Poplawski; Jerzy Sarosiek
Journal:  Dig Dis Sci       Date:  2011-06-22       Impact factor: 3.199

7.  Role of saliva in esophageal defense: implications in patients with nonerosive reflux disease.

Authors:  Harathi Yandrapu; Marek Marcinkiewicz; Cezary Poplawski; Kyung Han; Tomasz Zbroch; George Goldin; Irene Sarosiek; Zbigniew Namiot; Jerzy Sarosiek
Journal:  Am J Med Sci       Date:  2015-05       Impact factor: 2.378

8.  Salivary transforming growth factor alpha in patients with Sjögren's syndrome and reflux laryngitis.

Authors:  Marco Antonio dos Anjos Corvo; Claudia Alessandra Eckley; Luis Vicente Rizzo; Luiz Roberto Sardinha; Tomas Navarro Rodriguez; Ivo Bussoloti Filho
Journal:  Braz J Otorhinolaryngol       Date:  2014-08-27

9.  Influence of smoking isolated and associated to multifactorial aspects in vocal acoustic parameters.

Authors:  Aline Gomes Lustosa Pinto; Agrício Nubiato Crespo; Lucia Figueiredo Mourão
Journal:  Braz J Otorhinolaryngol       Date:  2014 Jan-Feb
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.